Posted in | News | Nanobusiness

Rolith, Inc. Announce Issuance of US Patent No. 8,518,633 in the US

Rolith, Inc., a leader in advanced nanostructured devices, today announces the issuance of US patent no. 8,518,633 in the United States.

This key patent has already been issued in Japan and Russia. Further, it is currently pending for issuance in another 8 countries including China, Korea, Taiwan and Europe.

RML™ is based on near-field continuous optical lithography, which is implemented using cylindrical phase masks. The technology has been realized in lithography tools: RML-1 (300 mm x 300 mm printing area) and RML-2 (1000 mm x 300 mm printing area) build in partnership with a well-known semiconductor equipment company, SUSS MicroTec.

Rolith has additionally developed a proprietary technology for specialized cylindrical phase masks for RML tools and built a facility for manufacturing these masks in California. Recently we demonstrated cylindrical masks capable of continuous (gap/seam-free) nanopatterning on 1m long substrates.

“Receiving a core-technology patent is an important milestone for the company. It proves uniquiness of our approach, which enables high resolution large area low cost patterning, wih performance not matched by any other competing technologies”, said Dr Boris Kobrin, founder and CEO, Rolith. He adds: “Award of this core patent in the US allows us to aggressively pursue commercialization of our technology in application to consumer electronics, renewable energy and automotive markets. It also gives additional competitive advantage in these highly competitive fields.”

Rolith has been developing anti-reflective glass products in partnership with Asahi Glass Corp. Recently Rolith has launched a new application development – Transparent Metal Mesh Electrodes for touch screen sensors, OLED displays and lighting devices, and solar cells. Rolith’s “NanoWeb ™” electrodes are superior to all ITO-alternative products currently on the market.

About Rolith, Inc.

Rolith, Inc. is developing advanced nanostructured products for consumer electronics, solar and green building markets using a proprietary nanolithography technology. Rolith was formed by Dr. Boris Kobrin, Prof. Mark Brongersma and Julian Zegelman in 2008 and is currently located in Pleasanton, CA.

The company holds a comprehensive patent portfolio in the areas of nanolithography, material deposition and etch methods, as well as nanophotonic devices. Rolith’s strategic partners include SUSS MicroTec AG and Asahi Glass Company Ltd. Its current investors are DFJ VTB Capital Aurora, a Draper Fisher Jurvetson affiliate fund managed by VTB Capital and AGC America, Inc., the venture arm of Asahi Glass Group.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rolith. (2019, February 11). Rolith, Inc. Announce Issuance of US Patent No. 8,518,633 in the US. AZoNano. Retrieved on May 08, 2024 from https://www.azonano.com/news.aspx?newsID=28427.

  • MLA

    Rolith. "Rolith, Inc. Announce Issuance of US Patent No. 8,518,633 in the US". AZoNano. 08 May 2024. <https://www.azonano.com/news.aspx?newsID=28427>.

  • Chicago

    Rolith. "Rolith, Inc. Announce Issuance of US Patent No. 8,518,633 in the US". AZoNano. https://www.azonano.com/news.aspx?newsID=28427. (accessed May 08, 2024).

  • Harvard

    Rolith. 2019. Rolith, Inc. Announce Issuance of US Patent No. 8,518,633 in the US. AZoNano, viewed 08 May 2024, https://www.azonano.com/news.aspx?newsID=28427.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.